Ohbe Hiroyuki, Satoh Kasumi, Totoki Takaaki, Tanikawa Atsushi, Shirasaki Kasumi, Kuribayashi Yoshihide, Tamura Miku, Takatani Yudai, Ishikura Hiroyasu, Nakamura Kensuke
Department of Emergency and Critical Care Medicine, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Crit Care. 2024 Dec 28;28(1):435. doi: 10.1186/s13054-024-05215-4.
Medical advances in intensive care units (ICUs) have resulted in the emergence of a new patient population-those who survive the initial acute phase of critical illness, but require prolonged ICU stays and develop chronic critical symptoms. This condition, often termed Persistent Critical Illness (PerCI) or Chronic Critical Illness (CCI), remains poorly understood and inconsistently reported across studies, resulting in a lack of clinical practice use. This scoping review aims to systematically review and synthesize the existing literature on PerCI/CCI, with a focus on definitions, epidemiology, and outcomes for its translation to clinical practice.
A scoping review was conducted using MEDLINE and Scopus, adhering to the PRISMA-ScR guidelines. Peer-reviewed original research articles published until May 31, 2024 that described adult PerCI/CCI in their definitions of patient populations, covariates, and outcomes were included. Data on definitions, epidemiology, and outcomes were extracted by a data charting process from eligible studies and synthesized.
Ninety-nine studies met the inclusion criteria. Of these studies, 64 used the term CCI, 18 used PerCI, and 17 used other terms. CCI definitions showed greater variability, while PerCI definitions remained relatively consistent, with an ICU stay ≥ 14 days for CCI and ≥ 10 days for PerCI being the most common. A meta-analysis of the prevalence of PerCI/CCI among the denominators of "all ICU patients", "sepsis", "trauma", and "COVID-19" showed 11% (95% confidence interval 10-12%), 28% (22-34%), 24% (15-33%), and 35% (20-50%), respectively. A meta-analysis of in-hospital mortality was 27% (26-29%) and that of one-year mortality was 45% (32-58%). Meta-analyses of the prevalence of CCI and PerCI showed 17% (16-18%) and 18% (16-20%), respectively, and those for in-hospital mortality were 28% (26-30%) and 26% (24-29%), respectively. Functional outcomes were generally poor, with many survivors requiring long-term care.
This scoping review synthesized many studies on PerCI/CCI, highlighting the serious impact of PerCI/CCI on patients' long-term outcomes. The results obtained underscore the need for consistent terminology with high-quality research for PerCI/CCI. The results obtained provide important information to be used in discussions with patients and families regarding prognosis and care options.
重症监护病房(ICU)的医学进展导致了一种新的患者群体的出现,即那些在危重病的初始急性期存活下来,但需要在ICU长期住院并出现慢性危重症症状的患者。这种情况通常被称为持续性危重病(PerCI)或慢性危重病(CCI),目前人们对其了解甚少,且各研究报告不一致,导致其在临床实践中缺乏应用。本综述旨在系统回顾和综合关于PerCI/CCI的现有文献,重点关注其定义、流行病学及转归,以便应用于临床实践。
按照PRISMA-ScR指南,使用MEDLINE和Scopus进行综述。纳入截至2024年5月31日发表的、在患者群体定义、协变量和转归方面描述成人PerCI/CCI的同行评审原始研究文章。通过数据图表过程从符合条件的研究中提取关于定义、流行病学和转归的数据并进行综合。
99项研究符合纳入标准。其中,64项研究使用了CCI一词,18项使用了PerCI,17项使用了其他术语。CCI的定义差异较大,而PerCI的定义相对一致,最常见的是CCI的ICU住院时间≥14天,PerCI的ICU住院时间≥10天。对“所有ICU患者”“脓毒症”“创伤”和“COVID-19”分母中PerCI/CCI患病率的荟萃分析显示,患病率分别为11%(95%置信区间10-12%)、28%(22-34%)、24%(15-33%)和35%(20-50%)。住院死亡率的荟萃分析结果为27%(26-29%),一年死亡率为45%(32-58%)。CCI和PerCI患病率的荟萃分析分别显示为17%(16-18%)和18%(16-20%),住院死亡率的荟萃分析分别为28%(26-30%)和26%(24-29%)。功能转归总体较差,许多幸存者需要长期护理。
本综述综合了许多关于PerCI/CCI的研究,突出了PerCI/CCI对患者长期转归的严重影响。所得结果强调了对PerCI/CCI需要统一术语并开展高质量研究。所得结果为与患者及其家属讨论预后和护理选择提供了重要信息。